First Take: F4Q & Initial FY25 Guide Look Good Optically, CSL Details Needed To Truly Judge

⬆ $Haemonetics Corp(HAE)$ - Thursday morning, Haemonetics released F4Q24 results that beat top-line consensus by ~4% with upside across segments leading to organic growth of...


Continue reading on Smartkarma:- https://www.smartkarma.com/insights/first-take-f4q-initial-fy25-guide-look-good-optically-csl-details-needed-to-truly-judge?utm_source=tiger_community

By CGS CIMB Research, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/cgs-cimb-research?utm_source=tiger_community

On Haemonetics Corp (HAE):- https://www.smartkarma.com/entities/haemonetics-corp?utm_source=tiger_community

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

举报

评论

  • 推荐
  • 最新
empty
暂无评论